Mandate

Vinge advised LumenRadio AB (publ) in connection with the listing on Nasdaq First North Growth Market

Vinge has advised LumenRadio AB (publ) (“LumenRadio”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 28 November 2022 and the first day of trading occurred on 8 December 2022.

The offering in connection with the listing was conducted at a fixed price of SEK 48 per share, corresponding to a market value for LumenRadio’s shares of approximately SEK 544 million before the offering and approximately SEK 594 million after the completion of the offering.

LumenRadio is a Gothenburg based technology company focusing on developing and selling reliable wireless product-to-product connections for business-critical applications within the Internet of Things (“IoT”). LumenRadio offers scalable solutions that build on proprietary and patented technology for future-proof wireless data transfer on open frequency bands, replacing traditional cables for control and automation. LumenRadio has around 60 employees and is headquartered in Gothenburg, with two small sales offices in Frankfurt and Boston.

Vinge’s team primarily consisted of Magnus Pauli, Edin Agic (Project Manager), Petronella Hallberg, Adrian Filipovic, Amelia Rihs, Hanna Jansson (Capital Markets and Public M&A), Anna Högsten, Victoria Gunnerek (Employment and Sanctions) and Amanda Stoltz (VDR).

 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024